NASDAQ:MRNS

Marinus Pharmaceuticals - MRNS Earnings Date, Estimates & Call Transcripts

$5.47

-0.22 (-3.87%)

(As of 08/9/2022 12:00 AM ET)

Add

Compare

Today's Range: $5.36
▼
$5.87
50-Day Range: $4.09
▼
$6.21
52-Week Range: $3.97
▼
$13.58

Volume: 293,375 shs
Average Volume: 322,646 shs
Market Capitalization: $203.16 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $32.14

Upcoming Earnings Date: Aug. 11Confirmed
Actual EPS (May. 12): -$0.52 Beat By $0.35
Consensus EPS (May. 12): -$0.87
Last Year's Q2 EPS (5/17/2021): -$0.74

Earnings Per Share Revenue

MRNS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRNS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Marinus Pharmaceuticals Analyst Forecasts

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2022	5	($0.94)	($0.07)	($0.69)
Q2 2022	5	($0.95)	$1.47	($0.38)
Q3 2022	5	($1.07)	($0.79)	($0.97)
Q4 2022	5	($1.12)	($0.62)	($0.94)
FY 2022	20	($4.08)	($0.01)	($2.99)
Q1 2023	1	($1.12)	($1.12)	($1.12)
Q2 2023	1	($1.14)	($1.14)	($1.14)
Q3 2023	1	($0.90)	($0.90)	($0.90)
Q4 2023	1	($0.92)	($0.92)	($0.92)
FY 2023	4	($4.08)	($4.08)	($4.08)

MRNS Earnings Date and Information

Marinus Pharmaceuticals last announced its quarterly earnings results on May 12th, 2022. The biopharmaceutical company reported ($0.52) EPS for the quarter, beating the consensus estimate of ($0.87) by $0.35. The business had revenue of $14.19 million for the quarter, compared to the consensus estimate of $2.19 million. Marinus Pharmaceuticals has generated ($2.47) earnings per share over the last year (($2.47) diluted earnings per share). Earnings for Marinus Pharmaceuticals are expected to decrease in the coming year, from ($2.33) to ($3.76) per share. Marinus Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, August 11th, 2022. Marinus Pharmaceuticals will be holding an earnings conference call on Thursday, August 11th at 8:30 AM Eastern. Interested parties can register for or listen to the call..

Marinus Pharmaceuticals Earnings History by Quarter

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
8/11/2022 (Confirmed)		($0.93)
5/12/2022	Q1 2022	($0.87)	($0.52)	+$0.35	($0.52)	$2.19 million	$14.19 million
3/21/2022	Q4 2021	($0.81)	($0.77)	+$0.04	($0.77)	$2.64 million	$1.52 million
11/9/2021	9/30/2021	($0.76)	($0.53)	+$0.23	($0.53)	$2.32 million	$10.11 million
8/10/2021	6/30/2021	($0.68)	($0.65)	+$0.03	($0.65)	$2.57 million	$1.91 million
5/17/2021	3/31/2021	($0.46)	($0.74)	($0.28)	($0.74)	$2.61 million	$1.81 million
3/8/2021	12/31/2020	($0.52)	($0.55)	($0.03)	($0.55)	$1.77 million	$1.55 million
11/9/2020	9/30/2020	($0.60)	($0.51)	+$0.09	($0.51)
8/6/2020	6/30/2020	($0.76)	($0.64)	+$0.12	($0.16)
5/4/2020	3/31/2020	($0.64)	($1.28)	($0.64)	($0.32)
3/16/2020	12/31/2019	($0.84)	($1.00)	($0.16)	($0.26)

11/6/2019	Q3	($0.9480)	($1.04)	($0.0920)	($0.26)
8/8/2019	Q2 2019	($0.9360)	($0.96)	($0.0240)	($0.24)
5/1/2019	Q1 2019	($0.8480)	($0.96)	($0.1120)	($0.24)
3/11/2019	12/31/2018	($1.04)	($0.96)	+$0.08	($0.24)
10/29/2018	9/30/2018	($0.84)	($1.08)	($0.24)	($0.27)
8/2/2018	Q2 2018	($0.60)	($0.96)	($0.36)	($0.24)
5/2/2018	Q1 2018	($0.64)	($0.60)	+$0.04	($0.15)
3/6/2018	Q4 2017	($0.52)	($0.80)	($0.28)	($0.20)
10/31/2017	Q3 2017	($0.68)	($0.60)	+$0.08	($0.15)
8/1/2017	Q2 2017	($1.08)	($0.84)	+$0.24	($0.21)
5/1/2017	Q1 2017	($1.28)	($1.04)	+$0.24	($0.26)
3/13/2017	Q4 2016	($1.32)	($1.24)	+$0.08	($0.31)
11/3/2016	Q3	($1.72)	($1.32)	+$0.40	($0.33)
8/9/2016	Q2	($1.52)	($1.84)	($0.32)	($0.46)
5/2/2016	Q1 2016	($1.64)	($1.48)	+$0.16	($0.37)
3/7/2016	Q416	($1.52)	($1.80)	($0.28)	($0.45)
10/29/2015	Q3 2015	($2.04)	($1.40)	+$0.64	($0.35)
8/4/2015	Q2 2015	($2.04)	($1.48)	+$0.56	($0.37)
5/11/2015	Q1 2015	($1.88)	($2.00)	($0.12)	($0.50)
3/12/2015	Q4 2014		($1.04)	($1.04)	($0.26)
11/13/2014	Q3 14	($2.00)	($1.20)	+$0.80	($0.38)

Marinus Pharmaceuticals Earnings - Frequently Asked Questions

When is Marinus Pharmaceuticals's earnings date?: Marinus Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Thursday, August 11th, 2022. Learn more on MRNS's earnings history.
Did Marinus Pharmaceuticals beat their earnings estimates last quarter?: In the previous quarter, Marinus Pharmaceuticals (NASDAQ:MRNS) reported ($0.52) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.87) by $0.35. Learn more on analysts' earnings estimate vs. MRNS's actual earnings.

How much revenue does Marinus Pharmaceuticals generate each year?: Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded annual revenue of $15.35 million.
How much profit does Marinus Pharmaceuticals generate each year?: Marinus Pharmaceuticals (NASDAQ:MRNS) has a recorded net income of -$98.78 million. MRNS has generated -$2.47 earnings per share over the last four quarters.
What is Marinus Pharmaceuticals's EPS forecast for next year?: Marinus Pharmaceuticals's earnings are expected to decrease from ($2.33) per share to ($3.76) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:

Earnings By Country:

Latest Articles:

Upcoming Earnings:

Brookfield Asset Management (8/11/2022)
BHP Group (8/16/2022)
Walmart (8/16/2022)
Home Depot (8/16/2022)
Cisco Systems (8/17/2022)
Analog Devices (8/17/2022)
Synopsys (8/17/2022)
TJX Companies (8/17/2022)
Target (8/17/2022)
Lowe's Companies (8/17/2022)

This page (NASDAQ:MRNS) was last updated on 8/10/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources